Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,111 | 66 | 94.5% |
| Education | $64.99 | 1 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HARMONY BIOSCIENCES LLC | $175.24 | 13 | $0 (2024) |
| ABBVIE INC. | $160.04 | 8 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $118.21 | 6 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $91.24 | 5 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $89.73 | 6 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $75.98 | 4 | $0 (2024) |
| Alkermes, Inc. | $66.10 | 4 | $0 (2024) |
| Corium, LLC | $65.10 | 4 | $0 (2024) |
| LivaNova USA, Inc. | $55.05 | 2 | $0 (2024) |
| Axsome Therapeutics, Inc. | $46.81 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $622.49 | 35 | HARMONY BIOSCIENCES LLC ($159.59) |
| 2023 | $400.07 | 22 | ABBVIE INC. ($52.33) |
| 2022 | $85.21 | 6 | Teva Pharmaceuticals USA, Inc. ($24.50) |
| 2021 | $67.77 | 4 | Janssen Pharmaceuticals, Inc ($44.93) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Neurology | ||||||
| 12/05/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.53 | General |
| Category: Narcoplepsy | ||||||
| 12/05/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $2.29 | General |
| Category: Narcoplepsy | ||||||
| 11/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.47 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: CNS | ||||||
| 11/06/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.51 | General |
| Category: Narcoplepsy | ||||||
| 11/05/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Neurology | ||||||
| 11/04/2024 | LivaNova USA, Inc. | VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) | Food and Beverage | In-kind items and services | $26.27 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: PSYCHIATRY | ||||||
| 10/15/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $25.89 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: Neuropsychiatry | ||||||
| 10/02/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $14.12 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/17/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $64.99 | General |
| Category: Narcoplepsy | ||||||
| 09/10/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $9.21 | General |
| Category: Narcoplepsy | ||||||
| 08/29/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $7.32 | General |
| Category: Narcoplepsy | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/29/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $7.78 | General |
| Category: Narcoplepsy | ||||||
| 07/09/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Neurology | ||||||
| 06/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: PSYCHIATRY | ||||||
| 06/02/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 05/29/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $19.21 | General |
| Category: Narcoplepsy | ||||||
| 05/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: Neuroscience | ||||||
| 05/13/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $8.23 | General |
| Category: Narcoplepsy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 128 | 481 | $93,261 | $27,891 |
| 2022 | 4 | 152 | 612 | $114,360 | $35,332 |
| 2021 | 6 | 195 | 560 | $91,592 | $30,874 |
| 2020 | 7 | 211 | 487 | $70,328 | $21,841 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 256 | $59,197 | $18,033 | 30.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 28 | 80 | $13,004 | $3,959 | 30.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 18 | 54 | $10,042 | $3,021 | 30.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 18 | 52 | $7,452 | $1,965 | 26.4% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 11 | 39 | $3,566 | $912.86 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 283 | $63,891 | $20,491 | 32.1% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 34 | 142 | $25,871 | $7,084 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 36 | 113 | $17,995 | $5,775 | 32.1% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 18 | 74 | $6,603 | $1,982 | 30.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 53 | 198 | $43,261 | $14,954 | 34.6% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 24 | 84 | $14,924 | $4,529 | 30.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 80 | $12,218 | $3,962 | 32.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 43 | 129 | $10,520 | $3,677 | 34.9% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 26 | 57 | $7,507 | $2,836 | 37.8% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 12 | 12 | $3,162 | $916.41 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 98 | $20,086 | $5,170 | 25.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 37 | 106 | $13,356 | $5,000 | 37.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 44 | 115 | $16,243 | $4,761 | 29.3% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 36 | 86 | $6,536 | $2,292 | 35.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 16 | 30 | $5,220 | $1,790 | 34.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 18 | 38 | $5,174 | $1,666 | 32.2% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 14 | 14 | $3,713 | $1,162 | 31.3% |
About Brooke Lyons, ARNP
Brooke Lyons, ARNP is a Nurse Practitioner healthcare provider based in Dubuque, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/24/2014. The National Provider Identifier (NPI) number assigned to this provider is 1225430077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brooke Lyons, ARNP has received a total of $1,176 in payments from pharmaceutical and medical device companies, with $622.49 received in 2024. These payments were reported across 67 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,111).
As a Medicare-enrolled provider, Lyons has provided services to 686 Medicare beneficiaries, totaling 2,140 services with total Medicare billing of $115,938. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Location Dubuque, IA
- Active Since 09/24/2014
- Last Updated 10/16/2018
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1225430077
Products in Payments
- WAKIX (Drug) $175.24
- VRAYLAR (Drug) $160.04
- REXULTI (Drug) $70.94
- Azstarys (Drug) $65.10
- CAPLYTA (Drug) $63.49
- SPRAVATO (Drug) $60.70
- VNS THERAPY SYMMETRY MODEL 8103 GENERATOR (Device) $55.05
- Sunosi (Drug) $46.81
- INGREZZA (Drug) $45.40
- Qelbree (Drug) $40.89
- UZEDY (Drug) $37.38
- ARISTADA (Drug) $36.86
- QELBREE (Drug) $35.09
- JORNAY PM (Drug) $34.82
- Austedo XR (Drug) $29.36
- LYBALVI (Drug) $29.24
- INVEGA SUSTENNA (Drug) $29.03
- ABILIFY MAINTENA (Drug) $25.89
- AUSTEDO (Drug) $24.50
- ABILIFY ASIMTUFII (Drug) $21.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Dubuque
Karena Sauser, Arnp, ARNP
Nurse Practitioner — Payments: $1,836
Julie Ehlinger, A.r.n.p, A.R.N.P
Nurse Practitioner — Payments: $1,072
Dr. Christina Mcnamara, Dnp, DNP
Nurse Practitioner — Payments: $849.96
Tony Heiar, Np, NP
Nurse Practitioner — Payments: $802.46
Emily Miller
Nurse Practitioner — Payments: $480.14
Christine Burds, A.r.n.p, A.R.N.P
Nurse Practitioner — Payments: $282.31